2021³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-09-04±³À°ÀÏÀÚ : 2021-09-04
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà)2021³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À°ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ (ÀÌ»çÀåÁ¦)
´ã´çÀÚ : °íÀº¾ç
¿¬¶ôó : 070-4888-5731
À̸ÞÀÏ :
ksbtp.svc@gmail.com ±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 13 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í »çÀüµî·Ï-Àü¹®ÀÇ 40,000¿ø/±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 20,000¿ø/°£È£»ç,ÀÓ»ó½É¸®»ç,»çȸº¹Áö»ç 20,000¿ø/Æò»ýȸ¿ø-¸éÁ¦ÇöÀåµî·Ï-¾øÀ½
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 09:40~10:05 Development of a new therapeutic method to prevent neuronal inflammation using gut microbiota Àå½ÂÈ£(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 10:05~10:30 Drug research through development of biomimetic system using 3D-neuronal spheroid ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 10:30~10:55 Clinical efficacy and safety of transcranial direct current stimulation (tDCS) in major depressive disorder through home clinical trials À̱â¿ø(Ybrain)
Åä·Ð 09-04 ¿Â¶óÀÎ 10:55~11:05 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 11:15~11:40 New drugs expected to be effective in the treatment of schizophrenia and psychotic symptoms À̺´´ë(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 11:40~12:05 Promising new drugs effective in the treatment of bipolar disorder ¹®Àº¼ö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 12:05~12:30 Promising drugs for the treatment of mental disorders in children and adolescents ±è°æ¹Ì(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 09-04 ¿Â¶óÀÎ 12:30~12:40 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 12:40~13:40 Reliable Long-term Management That prevents Recurrences and preserves Functioning through Long Acting Injectable Antipsychotics in Bipolar disorder ÀÓÀº¼º(½Å¼¼°è È¿º´¿ø)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 14:00~14:25 How should we diagnose and treat fibromyalgia? ±è¼ºÈ£(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 14:25~14:50 Chronic pain and sleep disorders ¹æ¿µ·Õ(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 14:50~15:15 Antidepressants: another weapon against chronic pain Àå¼¼Çå(ºÀ»ýº´¿ø)
Åä·Ð 09-04 ¿Â¶óÀÎ 15:15~15:25 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 15:35~16:00 Anticholinergic Drugs and Incident Dementia, Mild Cognitive Impairment and Cognitive Decline À±¼¿µ(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 16:00~16:25 Psychosis in Neurodegenerative Disease: Differential Patterns of Hallucination and Delusion Symptoms Àüµ¿¿í(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 16:25~16:50 Opportunities and possibilities of new monoclonal antibody drugs in the treatment of Alzheimer ÀÌ¿µ¹Î(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 16:50~17:00 ÁúÀÇ ¹× Åä·Ð ()
Åä·Ð 09-04 ¿Â¶óÀÎ 09:40~10:05 Research domain criteria ±è°æ¿ø(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 10:05~10:30 Endophenotypes in psychiatric illness ¼ÇýÁø(¿ëÀÎÁ¤½Åº´¿ø)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 10:30~10:55 Artificial intelligence and the future of psychiatry ¼ÛÁØ¿µ(KAIST)
Åä·Ð 09-04 ¿Â¶óÀÎ 10:55~11:05 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 11:15~11:40 Current neuroimaging techniques in dementia ±èÇý±Ý(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 11:40~12:05 Biomarkers and endophenotypes of dementia ±èº´¼ö(°æºÏÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 12:05~12:30 Current and future treatments in dementia ÀÌÁ¤Àç(´Ü±¹ÀÇ´ë)
Åä·Ð 09-04 ¿Â¶óÀÎ 12:30~12:40 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 12:40~13:40 Role of bupropion in MDD patients ±è¾çÅÂ(°è¸íÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 14:00~14:25 Assessment and diagnosis of PTSD °Å¿í(À»ÁöÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 14:25~14:50 Pathophysiology and endophenotypes of PTSD Á¤¿ì¿µ(¾ç»êºÎ»êÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 14:50~15:15 Evidence based treatments for PTSD Á¤¼º¿ø(°è¸íÀÇ´ë)
Åä·Ð 09-04 ¿Â¶óÀÎ 15:15~15:25 ÁúÀÇ ¹× Åä·Ð ()
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 15:35~16:00 Endophenotypes of depression Á¤ÈñÁ¤(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 16:00~16:25 Neuromodulation for depression ¿ÀÁÖ¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-04 ¿Â¶óÀÎ 16:25~16:50 Digital healthcare technology in depression Á¶µ¿·¡(µö¸Þµð)
Åä·Ð 09-04 ¿Â¶óÀÎ 16:50~17:00 ÁúÀÇ ¹× Åä·Ð ()